DMD Large equally mixed donor pool

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on January 19, 2007; DOI: 10.1124/dmd.106.014084


0090-9556/07/3504-508-514$20.00
DMD 35:508-514, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.014084v1
35/4/508    most recent
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Higashi, E.
Right arrow Articles by Yokoi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Higashi, E.
Right arrow Articles by Yokoi, T.
SHORT COMMUNICATION

Inhibitory Effects of Neurotransmitters and Steroids on Human CYP2A6

Eriko Higashi, Miki Nakajima, Miki Katoh, Shogo Tokudome, and Tsuyoshi Yokoi

Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan (E.H., M.N., M.K., T.Y.); and Department of Legal Medicine, Dokkyo University School of Medicine, Tochigi, Japan (S.T.)

Human CYP2A6 catalyzes the metabolism of nicotine, cotinine, and coumarin as well as some pharmaceutical drugs. CYP2A6 is highly expressed in liver and, also, in brain and steroid-related tissues. In this study, we investigated the inhibitory effects of neurotransmitters and steroid hormones on CYP2A6 activity. We found that coumarin 7-hydroxylation and cotinine 3'-hydroxylation by recombinant CYP2A6 expressed in baculovirus-infected insect cells were competitively inhibited by tryptamine (both Ki = 0.2 µM), serotonin (Ki = 252 µM and 167 µM), dopamine (Ki = 49 µM and 22 µM), and histamine (Ki = 428 µM and 359 µM). Cotinine formation from nicotine was inhibited by tryptamine (Ki = 0.7 µM, competitive), serotonin (Ki = 272 µM, noncompetitive), dopamine, noradrenaline, and adrenaline (Ki = 11 µM, 54 µM, and 81 µM, uncompetitive). Estrogens (Ki = 0.6–3.8 µM), androgens (Ki = 60–149 µM), and corticosterone (Ki = 36 µM) also inhibited cotinine formation, but coumarin 7-hydroxylation and cotinine 3'-hydroxylation did not. Nicotine-{Delta}5'(1')-iminium ion formation from nicotine was not affected by these steroid hormones, indicating that the inhibition of cotinine formation was due to the inhibitory effects on aldehyde oxidase. The nicotine-{Delta}5'(1')-iminium ion formation was competitively inhibited by tryptamine (Ki = 0.3 µM), serotonin (Ki = 316 µM), dopamine (Ki = 66 µM), and histamine (Ki = 209 µM). Thus, we found that some neurotransmitters inhibit CYP2A6 activity, being related with inter- and intraindividual differences in CYP2A6-dependent metabolism. The inhibitory effects of steroid hormones on aldehyde oxidase may also contribute to interindividual differences in nicotine metabolism.


Address correspondence to: Dr. Miki Nakajima, Drug Metabolism and Toxicology, Division of Pharmaceutical Sciences, Graduate School of Medical Science, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan. E-mail: nmiki{at}kenroku.kanazawa-u.ac.jp




This article has been cited by other articles:


Home page
Hum Exp ToxicolHome page
B Sinues, A Fanlo, E Mayayo, C Carcas, J Vicente, I Arenaz, and A Cebollada
CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives
Human and Experimental Toxicology, May 1, 2008; 27(5): 367 - 372.
[Abstract] [PDF]

eLetters:

Read all eLetters

Inhibitory Effects of Neurotransmitters and Steroids on Human CYP2A6
Jose AG Agundez, et al.
DMD Online, 6 Apr 2007 [Full text]
Response to letter from J. Agundez
Miki Nakajima
DMD Online, 6 Apr 2007 [Full text]



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.